← Leaderboards
Preet M. Chaudhary
University Of Texas Sw Med Ctr/Dallas
$12,007,840
Attributed
$12,007,840
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–20$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$12,007,840 · 10
By mechanism
R01$11,337,912 · 7
R21$559,626 · 2
P30$110,302 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Apoptosis”
- David Heimbrook · Leidos Biomedical Research, Inc.$49,205,802
- Jay A Nelson · Oregon Health & Science University$45,942,124
- John C Reed · University Of Texas Md Anderson Can Ctr$34,437,189
- John A Tainer · Scripps Research Institute$30,637,655
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$28,872,594
- John D Minna · University Of Texas Sw Med Ctr/Dallas$27,317,167
Research focus
ApoptosisHuman Herpesvirus 8LymphomaCell ProliferationNamesOpen Reading FramesPhosphotransferasesViral ProteinsCytokineCasp8 And Fadd-Like Apoptosis Regulating ProteinInfectionLinkMulticentric Angiofollicular Lymphoid HyperplasiaKaposi SarcomaComplexPathway InteractionsLeadMalignant NeoplasmsPathogenesisCellsViralCell LineMetaplastic Cell TransformationAcquired Immunodeficiency Syndrome
Grant awards (48)
Role of IKK epsilon in KSHV/HHV8 associated malignancies$412,500
R01 · FY2020 · DE · contact PI
Role of IKK epsilon in KSHV/HHV8 associated malignancies$412,500
R01 · FY2019 · DE · contact PI
Role of IKK epsilon in KSHV/HHV8 associated malignancies$412,500
R01 · FY2018 · DE · contact PI
Role of IKK epsilon in KSHV/HHV8 associated malignancies$412,500
R01 · FY2017 · DE · contact PI
Role of IKK epsilon in KSHV/HHV8 associated malignancies$412,500
R01 · FY2016 · DE · contact PI
Cell Penetrating Helical Peptide Inhibitors of vFLIP K13$388,922
R01 · FY2014 · DE · contact PI
Cell Penetrating Helical Peptide Inhibitors of vFLIP K13$373,366
R01 · FY2013 · DE · contact PI
Cell Penetrating Helical Peptide Inhibitors of vFLIP K13$388,922
R01 · FY2012 · DE · contact PI
A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera$260,852
R01 · FY2012 · CA · contact PI
Cell Penetrating Helical Peptide Inhibitors of vFLIP K13$381,065
R01 · FY2011 · DE · contact PI
Role of Arsenic Trioxide in Primary Effusion Lymphoma$298,566
R01 · FY2011 · CA · contact PI
A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera$260,852
R01 · FY2011 · CA · contact PI
Cell Penetrating Helical Peptide Inhibitors of vFLIP K13$393,052
R01 · FY2010 · DE · contact PI
Role of Arsenic Trioxide in Primary Effusion Lymphoma$294,464
R01 · FY2010 · CA · contact PI
A High Throughput Protein Complementation Assay for Inhibitors of NEMO-K13 Intera$268,920
R01 · FY2010 · CA · contact PI
Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig$260,465
R01 · FY2010 · CA · contact PI
Role of Arsenic Trioxide in Primary Effusion Lymphoma$12,225
R01 · FY2010 · CA · contact PI
Role of Arsenic Trioxide in Primary Effusion Lymphoma$278,239
R01 · FY2009 · CA · contact PI
Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig$236,627
R01 · FY2009 · CA · contact PI
Role of Arsenic Trioxide in Primary Effusion Lymphoma$278,353
R01 · FY2008 · CA · contact PI
Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig$236,554
R01 · FY2008 · CA · contact PI
Role of vFLIP K13 in Bone Marrow Failure Syndrome Associated with Infection by Hu$222,750
R21 · FY2008 · HL · contact PI
Small Molecule Inhibitors of K13-Induced NF-kB Activation$98,014
R21 · FY2008 · NS · contact PI
Small Molecule Inhibitors of K13-Induced NF-kB Activation$53,237
R21 · FY2008 · NS · contact PI
Role of Arsenic Trioxide in Primary Effusion Lymphoma$278,464
R01 · FY2007 · CA · contact PI
Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig$236,618
R01 · FY2007 · CA · contact PI
Role of vFLIP K13 in Bone Marrow Failure Syndrome Associated with Infection by Hu$185,625
R21 · FY2007 · HL · contact PI
Genes in X-linked Ectodermal Dysplasia Receptor$290,021
R01 · FY2006 · DE · contact PI
Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig$243,749
R01 · FY2006 · CA · contact PI
Role of orf-K13, an HHV8 Encoded vFLIP, in the Pathogenesis of AIDS-related Malig$100,000
R01 · FY2006 · CA · contact PI
Genes in X-linked Ectodermal Dysplasia Receptor$297,000
R01 · FY2005 · DE
Genes in X-linked Ectodermal Dysplasia Receptor$236,844
R01 · FY2004 · DE
ROLE OF ORF K13 IN AIDS RELATED MALIGNANCIES$216,352
R01 · FY2004 · CA
CASPASE 8 AND ITS HOMOLOGS IN NF-KB AND JNK ACTIVATION$178,341
R01 · FY2004 · AI
CASPASE 8 AND ITS HOMOLOGS IN NF-KB AND JNK ACTIVATION$85,652
R01 · FY2004 · AI
Genes in X-linked Ectodermal Dysplasia Receptor$63,195
R01 · FY2004 · DE
ROLE OF ORF K13 IN AIDS RELATED MALIGNANCIES$47,229
R01 · FY2004 · CA
Genes in X-linked Ectodermal Dysplasia Receptor$312,000
R01 · FY2003 · DE
CASPASE 8 AND ITS HOMOLOGS IN NF-KB AND JNK ACTIVATION$273,000
R01 · FY2003 · AI
ROLE OF ORF K13 IN AIDS RELATED MALIGNANCIES$255,904
R01 · FY2003 · CA
CASPASE 8 AND ITS HOMOLOGS IN NF-KB AND JNK ACTIVATION$273,000
R01 · FY2002 · AI
ROLE OF ORF K13 IN AIDS RELATED MALIGNANCIES$248,449
R01 · FY2002 · CA
CASPASE 8 AND ITS HOMOLOGS IN NF-KB AND JNK ACTIVATION$273,000
R01 · FY2001 · AI
ROLE OF ORF K13 IN AIDS RELATED MALIGNANCIES$241,213
R01 · FY2001 · CA
Signal transduction by EDAR, novel member of TNFR family$55,151
P30 · FY2001 · AR
CASPASE 8 AND ITS HOMOLOGS IN NF-KB AND JNK ACTIVATION$273,000
R01 · FY2000 · AI
ROLE OF ORF K13 IN AIDS RELATED MALIGNANCIES$240,937
R01 · FY2000 · CA
Signal transduction by EDAR, novel member of TNFR family$55,151
P30 · FY2000 · AR